Location History:
- Cambridge, MA (US) (2023)
- San Mateo, CA (US) (2024)
Company Filing History:
Years Active: 2023-2024
Title: The Innovations of Jason Paik - A Pioneer in B-cell Proliferative Disorder Treatments
Introduction
Jason Paik is a distinguished inventor based in Cambridge, MA, who has contributed significantly to medical innovations. With a total of three patents to his name, Jason has focused his research on advancing treatments for patients with B-cell proliferative disorders. His commitment to innovation has positioned him as a key figure in the field of biotechnology.
Latest Patents
Among Jason Paik's notable patents, two stand out for their contribution to the treatment of B-cell proliferative disorders. The first patent details a method of treating such disorders by administering zanubrutinib, or a pharmaceutically acceptable salt thereof, specifically for patients taking a moderate CYP3A inducer. This innovative approach recommends a dosage of approximately 320 mg twice daily, culminating in a total daily dose of about 640 mg. This treatment method not only addresses the disorder but also considers the unique pharmacological needs of the patient.
Career Highlights
Jason currently works at BeiGene Switzerland GmbH, where he collaborates with brilliant minds in the biomedical field to push the boundaries of scientific understanding and application. His innovative work has garnered recognition and respect among peers, making him a valuable contributor to his organization and the broader medical community.
Collaborations
In his career, Jason has partnered with several esteemed colleagues, including Tommi Salmi and Ying Ou. These collaborations have played an integral role in the development of his patents and highlight the importance of teamwork in advancing medical research.
Conclusion
Jason Paik's work exemplifies the spirit of innovation and dedication to improving patient care. His contributions, particularly in treating B-cell proliferative disorders, mark a significant advancement in medical treatments. With ongoing collaborations and research, Jason is poised to continue making impactful discoveries in the realm of biotechnology.